中国经济网北京1月14日讯 山东药玻（600529）(600529.SH)昨晚发布2026年度向特定对象发行A股股票 预案。山东药玻本次向特定对象发行募集资金总额为不超过323,511.88万元（含本数），扣除发行费用 后的募集资金净额将全部用于补充流动资金。 山东药玻公告表示，本次向特定对象发行股票的种类为人民币普通股（A股），每股面值为人民币1.00 元。本次发行的股票全部采取向特定对象发行的方式，公司将在上交所审核通过并经中国证监会作出同 意注册的批复后，在规定的有效期内择机发行。 本次向特定对象发行股票的发行对象为中国国际医药卫生有限公司、山东耀新健康产业有限公司，所有 发行对象均以人民币现金方式认购本次向特定对象发行的股票。 本次向特定对象发行股票的定价基准日为第十一届董事会第五次会议决议公告日。本次发行的发行价格 为16.25元/股，发行价格不低于定价基准日前20个交易日股票交易均价（定价基准日前20个交易日公司 股票交易均价=定价基准日前20个交易日股票交易总额/定价基准日前20个交易日股票交易总量）的 80%。如公司股票在本次发行定价基准日至发行日期间发生分红派息、送股、资本公积金转增股本等除 ...

Group 1 - A-shares experienced a decline on January 13, with the Shanghai Composite Index down 0.64% to 4138.76 points, ending a 17-day winning streak. The total trading volume reached a record high of 3.7 trillion yuan [1] - The U.S. President Trump announced the cancellation of all talks with Iranian officials, and the U.S. State Department urged citizens to leave Iran immediately. Iran's military claimed to have enhanced its capabilities in response to security threats [1] - The Federal Reserve Chairman Powell is under criminal investigation, with former financial officials criticizing the Trump administration's actions. Global central bank leaders are drafting a statement in support of Powell [1] Group 2 - Trump threatened to impose a 25% tariff on countries doing business with Iran, prompting a response from China's Foreign Ministry, which emphasized the need to maintain the stability of global supply chains for critical minerals [4] - The Ministry of Industry and Information Technology held a meeting with representatives from key industries, emphasizing participation in industry rule-making and self-regulation to resist "involution" [4] - The Ministry of Civil Affairs and other departments introduced 14 measures to promote high-quality development in elderly care services, with the elderly population expected to reach 310 million by 2024 and over 400 million by 2035 [4] Group 3 - The Hong Kong Hang Seng Index rose 0.9% to 26848.47 points, with medical stocks performing well. Southbound funds recorded a net purchase of 1.296 billion Hong Kong dollars [6] - The ETF management scale of Huaxia Fund surpassed 1 trillion yuan, marking a milestone in the domestic ETF market [6] - Two "commercial aerospace" concept stocks received regulatory warnings for inaccurate and incomplete information disclosures [6] Group 4 - A survey indicated that over 70% of insurance investment officers are optimistic about the investment outlook for 2026, with a preference for increasing equity asset allocations [7] - As of January 13, 186 listed companies had been investigated by institutions, with a focus on sectors like brain-computer interfaces and commercial aerospace [7] - More than 140 companies in the A-share market released performance forecasts for 2025, with 63 companies expecting profit increases [7] Group 5 - Companies in the mining sector are expected to see significant profit growth in 2025 due to rising gold prices, with companies like Chifeng Jilong Gold and Zijin Mining forecasting substantial profit increases [8] - The passing of David Webb, a prominent activist investor in Hong Kong, has raised concerns about the impact on the market [8] - China Europe Fund announced the suspension of certain fund activities, indicating a tightening of investment conditions [8] Group 6 - The Ministry of Industry and Information Technology outlined a plan for the development of industrial internet platforms, aiming for over 450 influential platforms by 2028 [11] - The Ministry of Commerce announced the continuation of anti-dumping duties on imported solar-grade polysilicon from the U.S. and South Korea [11] - A new round of high-value medical consumables procurement is set to open bidding, involving 12 types of medical consumables [11] Group 7 - Jiangsu Province released an "Artificial Intelligence+" action plan, targeting a trillion-yuan industry scale by 2027 [12] - The used car market in China is projected to exceed 20 million transactions in 2025, with a notable increase in the share of electric vehicles [12] - Significant advancements have been made in the development of high-performance sodium-ion battery materials [12] Group 8 - The global hedge fund industry achieved a 12.6% return in 2025, marking the strongest annual performance since the 2009 financial crisis [20] - JPMorgan reported a fourth-quarter revenue of $45.798 billion, exceeding market expectations, despite a decline in investment banking performance [20]

Group 1: Shanghai Pudong Development Bank - The bank reported a net profit of 50.017 billion yuan for 2025, an increase of 10.52% year-on-year [1][2] - Total operating income reached 173.964 billion yuan, reflecting a growth of 1.88% compared to the previous year [2] - The bank's total assets exceeded 1 trillion yuan, reaching 1,008.1746 billion yuan, a 6.55% increase from the previous year [3] Group 2: Dongpeng Beverage - Dongpeng Beverage expects a net profit between 4.34 billion and 4.59 billion yuan for 2025, representing a year-on-year growth of 30.46% to 37.97% [4] - The anticipated operating income is projected to be between 20.76 billion and 21.12 billion yuan, indicating a growth of 31.07% to 33.34% [4] Group 3: TCL Technology - TCL Technology forecasts a net profit of 4.21 billion to 4.55 billion yuan for 2025, marking a significant increase of 169% to 191% year-on-year [5][6] - The company expects to surpass 100 billion yuan in operating revenue, with net profit exceeding 8 billion yuan [5] Group 4: Changjiang Electric Power - Changjiang Electric Power reported a net profit of 34.167 billion yuan for 2025, a 5.14% increase year-on-year [8] - The total operating revenue for the year is expected to be 85.882 billion yuan, reflecting a growth of 1.65% [8] Group 5: China Gold - China Gold anticipates a net profit of 286 million to 368 million yuan for 2025, a decrease of 55% to 65% year-on-year [21] - The decline is attributed to market fluctuations and reduced consumer traffic [21] Group 6: LaKala - LaKala expects a net profit between 1.06 billion and 1.2 billion yuan for 2025, representing a growth of 202% to 242% year-on-year [22] - The increase is primarily due to significant investment income from stock holdings [22] Group 7: Baiwei Storage - Baiwei Storage projects a net profit of 850 million to 1 billion yuan for 2025, indicating a year-on-year increase of 427% to 520% [23] - The growth is driven by improved sales and gross margins in the AI sector [23] Group 8: Shengxin Lithium Energy - Shengxin Lithium Energy forecasts a net loss of 600 million to 850 million yuan for 2025, similar to the previous year's loss [24] - The company attributes the loss to industry supply-demand dynamics and increased exchange losses [24] Group 9: Zhongguancun Online - Zhongguancun Online expects a net loss of 580 million to 700 million yuan for 2025, a significant increase from the previous year's loss of 243 million yuan [25] - The losses are linked to increased promotional investments in overseas markets [25] Group 10: Huaxia Happiness - Huaxia Happiness anticipates a net loss of 16 billion to 24 billion yuan for 2025, a substantial increase from the previous year's loss of 4.817 billion yuan [26] - The decline is due to reduced project turnover and high financial costs [26]

Group 1: Company Announcements - Hongsheng Co., Ltd. has not generated revenue in the data center liquid cooling sector [1][2] - Oriental Pearl does not directly engage in AI business, and AI applications do not directly generate revenue [1][2] - Tongda Hai's AI-driven revenue accounts for a low proportion of the company's overall operating income [2] Group 2: Project Investments - Beibu Gulf Port plans to invest 11.403 billion yuan in the construction of a 300,000-ton terminal project in Fangcheng Port [1][2] - LeKai Film's subsidiary plans to invest 97.6675 million yuan in a TAC functional film coating production line project [2] Group 3: Contract Awards - Aopt has won a bid for a 120 million yuan 2D vision solution project for GoerTek in 2026 [1][2] - Anhui Expressway has won a project worth 7.237 billion yuan [2] Group 4: Equity Transfers - Aidi Pharmaceutical intends to acquire a 22.2324% stake in Nanda Pharmaceutical for 130 million yuan [1][2] Group 5: Share Buybacks - Kaifa Electric plans to repurchase shares worth between 30 million and 60 million yuan [1][2] - Haojiang Intelligent plans to repurchase shares worth between 1.5 million and 3 million yuan [3] - Huazhi Jie plans to invest 30 million to 50 million yuan in share repurchases [3] Group 6: Shareholding Changes - New Work Group, a shareholder of China New Group, plans to reduce its stake by no more than 3% [3] - Zhejiang Yongqiang's shareholder plans to reduce his stake by no more than 1.13% [3] - Xiangyu Medical's shareholder plans to reduce his stake by no more than 3% [3]

山东药玻(600529.SH)发布公告，公司拟向特定对象发行股票，募资总额不超过32.35亿元，净额将全部 用于补充流动资金。发行对象为中国医药集团有限公司全资子公司中国国际医药卫生有限公司及其全资 子公司国药国际香港有限公司的境内子公司山东耀新健康产业有限公司。本次发行将导致公司控制权发 生变化，发行完成后，中国国际医药卫生有限公司将成为公司的控股股东，公司的实际控制人将变更为 国药集团，最终控制人为国务院国资委。 山东药玻(600529.SH)发布公告，公司拟向特定对象发行股票，募资总额不超过32.35亿元，净额将全部 用于补充流动资金。发行对象为中国医药集团有限公司全资子公司中国国际医药卫生有限公司及其全资 子公司国药国际香港有限公司的境内子公司山东耀新健康产业有限公司。本次发行将导致公司控制权发 生变化，发行完成后，中国国际医药卫生有限公司将成为公司的控股股东，公司的实际控制人将变更为 国药集团，最终控制人为国务院国资委。 ...

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 山东药玻(600529.SH)公告称，公司收到鲁中投资通知，由于市场环境变化，经各方友好协商，决定终 止鲁中投资重组事宜。同时，公司拟向特定对象发行股份，由国药国际及其实控的山东耀新全额认购， 发行完成后，国药国际将成为公司控股股东，国药集团将成为公司实际控制人。此次发行旨在进一步提 升公司综合竞争力，实现高质量发展。 ...

每经头条（nbdtoutiao）——海利生物增值9倍并购的企业，估值8个月"腰斩"，其第一大客户竟是尚未 成立的公司，离奇的事还不少…… （记者 曾健辉） 每经AI快讯，山东药玻1月13日晚间发布公告称，本次向特定对象发行股票的相关事项已经公司第十一 届董事会第五次会议审议通过。本次向特定对象发行股票的发行对象为中国医药集团有限公司全资子公 司中国国际医药卫生有限公司及其全资子公司国药国际香港有限公司的境内子公司山东耀新健康产业有 限公司，本次向特定对象发行A股股票数量不超过约1.99亿股（含本数），发行数量不超过发行前上市 公司股份总数的30%，最终以上交所审核通过和中国证监会同意注册的发行数量为准。发行价格为 16.25元/股。扣除发行费用后，全部用于补充流动资金。 ...

发行对象为中国医药集团有限公司全资子公司中国国际医药卫生有限公司及其全资子公司国药国际香港 有限公司的境内子公司山东耀新健康产业有限公司。 本次发行将导致公司控制权发生变化，发行完成后，中国国际医药卫生有限公司将成为公司的控股股 东，公司的实际控制人将变更为中国医药集团有限公司，最终控制人为国务院国资委。 特别声明：以上内容仅代表作者本人的观点或立场，不代表新浪财经头条的观点或立场。如因作品内 容、版权或其他问题需要与新浪财经头条联系的，请于上述内容发布后的30天内进行。 来源：金综科技 1月13日，山东药玻公告称，公司拟向特定对象发行股票，募资总额不超过32.35亿元，用于补充流动资 金。 ...

智通财经APP讯，山东药玻(600529.SH)发布公告，公司拟向特定对象发行股票，募资总额不超过32.35 亿元，净额将全部用于补充流动资金。发行对象为中国医药集团有限公司全资子公司中国国际医药卫生 有限公司及其全资子公司国药国际香港有限公司的境内子公司山东耀新健康产业有限公司。本次发行将 导致公司控制权发生变化，发行完成后，中国国际医药卫生有限公司将成为公司的控股股东，公司的实 际控制人将变更为国药集团，最终控制人为国务院国资委。 ...

《附条件生效的股份认购协议》暨关联交易的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对 其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: ●山东省药用玻璃股份有限公司（以下简称"公司"）拟向特定对象发 行 A 股股票（以下简称"本次发行"），公司与中国国际医药卫生有限公司 （以下简称"国药国际"）及其全资子公司国药国际香港在境内设立的全资 子公司山东耀新健康产业有限公司（以下简称"山东耀新"）签署了《附条 件生效的股份认购协议》，约定由国药国际与山东耀新以现金方式认购公司 本次发行的股票。 ●截至本事项公告日，山东鲁中投资有限责任公司（以下简称"鲁中投 资"）持有公司股份的比例为19.50%，为公司控股股东，沂源县财政局为 公司实际控制人。 本次发行完成后，国药国际、山东耀新将合计持有山东药玻199,084,233 股股票，占本次发行后公司总股本的23.08%，公司的控股股东将变更为国 药国际，公司的实际控制人将变更为中国医药集团有限公司（以下简称"国 药集团"），最终控制人将变更为国务院国资委，本次发行将导致公司控 制权发生变化。 ●本次发行前，发 ...